title: Apoptotic cell death does not parallel other indicators of liver damage in chronic hepatitis C patients.
abstract: The mechanisms of hepatocyte damage and the events that lead to high rates of chronic liver disease in hepatitis C virus (HCV) infection remain unclear. Recent in vitro studies have suggested that the HCV core protein may disrupt specific signalling pathways of apoptosis. This prompted us to study patients with chronic HCV infection to: determine the extent of apoptosis in the liver; evaluate whether clinical and biochemical data are correlated with histological findings; and to investigate if apoptosis is related to the histological activity of the disease. Twelve patients with chronic hepatitis C were included in the study. Liver histology was scored by using the histological activity index (HAI) of Knodell et al. DNA fragmentation was assessed in liver tissue by the terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end-labelling (TUNEL) assay. Routine methods were used to determine serum markers of liver disease. Bile acids were measured in serum and liver by gas chromatography. Patients were placed, according to their HAI score, into group A (3.8 +/- 0.3) or group B (7.8 +/- 0.8) (P < 0.01). Liver enzymes tended to be higher in group B patients than in patients of group A. Levels of toxic bile acids in serum were greater in patients than in controls (P < 0.01). Chenodeoxycholic acid values were slightly higher in serum and liver of patients in group A. Liver biopsies with low HAI scores showed an increased rate of apoptosis (18.0 +/- 4.0 apoptotic cells per field) compared to those with higher HAI scores (6.6 +/- 2.1, P < 0.05) or to controls (3.5 +/- 0.4, P < 0.01). Hence, less severe liver disease, associated with lower histological grades and biochemistries, as well as increased levels of chenodeoxycholic acid, induces an expanded apoptotic response. The lower apoptotic rate in advanced liver disease may be associated with the high incidence of hepatocellular dysplasia/neoplasia.
authors.affiliation: Centro de Patog¿enese Molecular, Faculdade de Farm¿acia, University of Lisbon, Portugal.
authors.forename: C M
authors.initials: CM
authors.lastname: Rodrigues
authors.forename: D
authors.initials: D
authors.lastname: Brites
authors.forename: F
authors.initials: F
authors.lastname: Serejo
authors.forename: A
authors.initials: A
authors.lastname: Costa
authors.forename: F
authors.initials: F
authors.lastname: Ramalho
authors.forename: M C
authors.initials: MC
authors.lastname: De Moura
mesh_terms: D000328:Adult; D000368:Aged; D017209:Apoptosis; D001647:Bile Acids and Salts / Q000032:analysis / Q000097:blood; D015415:Biomarkers / Q000097:blood; D001706:Biopsy; D002635:Chenodeoxycholic Acid / Q000032:analysis / Q000097:blood; D002849:Chromatography, Gas; D053938:DNA Fragmentation; D005260:Female; D019698:Hepatitis C, Chronic / Q000097:blood / Q000473:pathology*; D006652:Histological Techniques; D006801:Humans; D008099:Liver / Q000166:cytology / Q000378:metabolism / Q000473:pathology*; D008297:Male; D008875:Middle Aged
chemical_list: D001647:Bile Acids and Salts; D015415:Biomarkers; D002635:Chenodeoxycholic Acid